search
Back to results

Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis

Primary Purpose

Septic Peritonitis

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
Midazolam
Propofol
Dexmedetomidine
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Septic Peritonitis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients aged18 years old or more and had the criteria of intraabdominal sepsis as evident by quick sofa score of 2 or more and have done intraabdominal surgical procedures

Exclusion Criteria:

  • children pregnant women Patients who receive neuromascular blockers during the first 48 hours of ICU admission known allergy or contraindication to propofol ,dexemedetomidine or midazolam known or suspected brain death

Sites / Locations

  • Faculty of Medicine, Assiut University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Experimental

Arm Label

midazolam

propofol

dexmedetomidine

Arm Description

postoperative ventilation and sedation with continuous intravenous infusion of midazolam only for 24 hours

postoperative ventilation and sedation with continuous intravenous infusion of propofol only for 24 hours

postoperative ventilation and sedation with continuous intravenous infusion of dexmedetomidine only for 24 hours

Outcomes

Primary Outcome Measures

interleukin 1 plasma concentration
interleukin 1 plasma concentration will be measured three times, at admission ,24 hours after admission and 48 hours after admission
interleukin 6 plasma concentration
interleukin 6 plasma concentration will be measured three times ,at admission ,24 hours after admission and 48 hours after admission
intraabdominal pressure per mmHg
intraabdominal pressure will be measured three times ,at admission ,24 hours after admission and 48 hours after admission

Secondary Outcome Measures

difference of mean time of ventilator free days
difference of mean time of ventilator free days between the three arms

Full Information

First Posted
January 15, 2021
Last Updated
April 24, 2021
Sponsor
Assiut University
search

1. Study Identification

Unique Protocol Identification Number
NCT04718714
Brief Title
Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis
Official Title
Effects of Dexmedetomidine vs Propofol on Inflammatory Response and Intra-abdominal Pressure in Patients With Intra-abdominal Sepsis; a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
January 23, 2021 (Actual)
Primary Completion Date
April 10, 2021 (Actual)
Study Completion Date
April 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Sepsis is defined as systemic response to infection ,and it is a main problem in ICU and despite advance in supportive care, the mortality rate in patients with severe sepsis continues to exceed 30% [Bone RC 1993].The effects of bacterial invasion of body tissues result from combined actions of enzymes and toxins produced by micro-organisms themselves and by a network of proinflammatory mediators and cytokines as tumour necrosis factor α and interleukin 6 which are overexpressed after various noxious insults[P.Delong et al. 2006],[ Yealy et al. 2014]. the patients who are subjected to abdominal surgery in order to treat the cause surgically,and many of these surgical procedures are lengthy and are at risk for either pre-operatively or post-operatively with steady increase in intra-abdominal pressure(IAP) [Malbrain ML et al. 2007] Intra-abdominal hypertension (IAH) is defined as IAP equal to or greater than 12 mmHg whereas abdominal compartment syndrome (ACS) is defined as IAP greater than 20 mmHg, abdominal perfusing pressure (APP) is used to predict prognosis of both IAH and ACS [Malbrain ML et al. 2006]. The choice for using a sedative agent in ICU for mechanically ventilated patients post-operatively is therefore a crucial one as these patients are under hyperstress state and often require drugs for sedation and analgesia[ Chanques G et al. 2006]. Analgesics and sedation agents have clearly been shown to alter cellular function and other mediators of immune system with wide range of immune modulation ,ranging from immunosuppressive effects to significant anti-inflammatory effects during endotoxaemia[ Taniguchi et al. 2004] Also sedation and /or analgesia have the potential to reduce IAP through improvement of abdominal wall compliance. Although propofol and dexmedetomidine are used for sedation in ICU there are limited data on their effects on inflammatory responses and IAP in septic patients. In clinical practice, septic patients treated with dexmedetomidine have shorter time on the ventilator as compared with those treated with lorazepam, a benzodiazepine and this beneficial effect of dexmedetomidine is more pronounced in septic patients than in nonseptic patients. This outcome may be partly the result of dexmedetomidine induced reduction in pulmonary inflammatory mediators and lung tissue damage.[ M. Ueki et al. 2014] Midazolam is known to inhibit certain aspects of the immune function. It was suggested that benzodiazepines bind to specific receptors on macrophages and inhibit their capacity to produce IL-1, IL-6, and TNFα. Propofol, nowadays, has become a preferred sedative in ICU because it offers advantages over benzodiazepines in terms of lack of accumulation, quick onset, easy adjustment, and fast recovery after discontinuation. [ Jacobi J et al. 2002]
Detailed Description
After surgery patients will be transferred to the ICU and will be randomly allocated by use of sealed envelopes ;into one of three groups 20 patients each. All ICU measurements will be recorded by an observer The following data will be collected: Patients' demographic and clinical data including age, sex, weight ,operative procedure time and type and patient's SOFA score. Mean arterial pressure, heart rate (HR), central venous pressure (CVP), and temperature will be continuously monitored . Urine output will be measured hourly and fluid balance will be calculated every 12 hours. All measurements will be obtained at the start of the study (baseline), then at the 24th and 48th hours. Lactate, platelets, leukocytes, bilirubin, alanine aminotransferase, and creatinine will be determined at the same times TNF-α, IL-1β, and IL-6 levels will be obtained at baseline, and at the 24th and 48 th hours. Intraabdominal pressure and abdominal perfusion pressure will be measured at baseline (15 min before start of the study) and at the 24th and 48th hours per the study protocol. Behavioral pain scale, ramsay sedation score and post operative analgesics requirements as a rescue analgesia. Duration of mechanical ventilation and length of ICU stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Peritonitis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
midazolam
Arm Type
Active Comparator
Arm Description
postoperative ventilation and sedation with continuous intravenous infusion of midazolam only for 24 hours
Arm Title
propofol
Arm Type
Active Comparator
Arm Description
postoperative ventilation and sedation with continuous intravenous infusion of propofol only for 24 hours
Arm Title
dexmedetomidine
Arm Type
Experimental
Arm Description
postoperative ventilation and sedation with continuous intravenous infusion of dexmedetomidine only for 24 hours
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Description
loading dose intravenous infusion of 0.2 mg/kg over 10 minutes followed by a maintenance dose of 0.02 -0.2 mg /kg/hr. over 24 hours.
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
loading dose intravenous infusion of one mg/kg over 15 minutes followed by a maintenance dose of 20-80 microgram/kg/min. over 24 hours.
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine
Intervention Description
loading dose of dexmedetomidine of one µg/kg over 10 minutes followed by maintenance dose of 0.2 -1.5 µg/kg/hr. over 24 hours.
Primary Outcome Measure Information:
Title
interleukin 1 plasma concentration
Description
interleukin 1 plasma concentration will be measured three times, at admission ,24 hours after admission and 48 hours after admission
Time Frame
48 hours
Title
interleukin 6 plasma concentration
Description
interleukin 6 plasma concentration will be measured three times ,at admission ,24 hours after admission and 48 hours after admission
Time Frame
48 hours
Title
intraabdominal pressure per mmHg
Description
intraabdominal pressure will be measured three times ,at admission ,24 hours after admission and 48 hours after admission
Time Frame
48 hours
Secondary Outcome Measure Information:
Title
difference of mean time of ventilator free days
Description
difference of mean time of ventilator free days between the three arms
Time Frame
28 days

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients aged18 years old or more and had the criteria of intraabdominal sepsis as evident by quick sofa score of 2 or more and have done intraabdominal surgical procedures Exclusion Criteria: children pregnant women Patients who receive neuromascular blockers during the first 48 hours of ICU admission known allergy or contraindication to propofol ,dexemedetomidine or midazolam known or suspected brain death
Facility Information:
Facility Name
Faculty of Medicine, Assiut University
City
Assiut
ZIP/Postal Code
71515
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis

We'll reach out to this number within 24 hrs